Tirilazad

Revision as of 17:30, 6 April 2015 by Aparna Vuppala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Tirilazad
Clinical data
Synonyms(8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC38H52N6O2
Molar mass624.859 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Tirilazad is a drug proposed to treat acute ischaemic stroke, however results are mixed as to whether the drug truly treats stroke.[1]

Mixed results

When tested on animal models, tirilazad protects brain tissue, and reduces any brain damage. On the contrary, the drug fails to treat, and even worsens a stroke when studied on a human being.

Usage in treatment of stroke

Tirilazad currently has no usage in the clinical treatment of stroke.

References

  1. "Tirilazad for acute ischaemic stroke". Retrieved 2007-07-28.

Template:Other nervous system drugs Template:Piperazines


Template:Nervous-system-drug-stub